Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 21 a 39 di 39
Titolo Data di pubblicazione Autore(i) File
Harmonemia: a universal strategy for flow cytometry immunophenotyping-A European LeukemiaNet WP10 study 1-gen-2016 Lacombe, F; Bernal, E; Bloxham, D; Couzens, S; Della Porta, M; Johansson, U; Kern, W; Macey, M; Matthes, T; Morilla, R; Paiva, A; Palacio, C; Preijers, F; Ratei, R; Siitonen, S; Allou, K; Porwit, A; Béné, Mc
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes. 1-gen-2008 DELLA PORTA, MATTEO GIOVANNI
Inflammation and multiple myeloma: the Toll connection. 1-gen-2006 Mantovani, A; Garlanda, C
Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF 1-gen-2005 Ricca, I.; Compagno, M.; Ladetto, M.; Rocci, A.; Dell'Aquila, M.; Omedè, P.; De Marco, F.; D'Antico, S.; Caracciolo, D.; Ferrero, D.; Carlo-Stella, C.; Tarella, C.
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes 1-gen-2015 DELLA PORTA, MATTEO GIOVANNI; Travaglino, E; Boveri, E; Ponzoni, M; Malcovati, Luca; Papaemmanuil, E; Rigolin, Gm; Pascutto, C; Croci, G; Gianelli, U; Milani, R; Ambaglio, I; Elena, Chiara; Ubezio, M; Da Via', Mc; Bono, E; Pietra, D; Quaglia, F; Bastia, R; Ferretti, V; Cuneo, A; Morra, E; Campbell, Pj; Orazi, A; Invernizzi, Rosangela; Cazzola, Mario
The novel PI3K-ò inhibitor TGR-1202 enhances brentuximab vedotin-induced Hodgkin lymphoma cell death via mitotic arrest. 1-gen-2016 Locatelli, S L; Careddu, G; Inghirami, G; Castagna, L; Sportelli, P; Santoro, A; Carlo-Stella, C
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts 1-gen-2013 Locatelli, S. L.; Giacomini, A.; Guidetti, A.; Cleris, L.; Mortarini, R.; Anichini, A.; Gianni, A.; Carlo Stella, C.
Platelet count predicts driver mutations' co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis 1-gen-2021 Mora, Barbara; Siracusa, Claudia; Rumi, Elisa; Maffioli, Margherita; Casetti, Ilaria Carola; Barraco, Daniela; Merli, Michele; Rossi, Marianna; Ubezio, Marta; Accetta, Raffaella; Libera, Laura; Pietra, Daniela; Trotti, Chiara; Uccella, Silvia; Pallotti, Francesco; Casalone, Rosario; Bertù, Lorenza; Arcaini, Luca; Della Porta, Matteo Giovanni; Passamonti, Francesco
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients 1-gen-2022 Mora, Barbara; Guglielmelli, Paola; Kuykendall, Andrew; Rumi, Elisa; Maffioli, Margherita; Palandri, Francesca; De Stefano, Valerio; Caramella, Marianna; Salmoiraghi, Silvia; Kiladjian, Jean-Jacques; Gotlib, Jason; Iurlo, Alessandra; Cervantes, Francisco; Ruggeri, Marco; Silver, Richard T; Albano, Francesco; Benevolo, Giulia; Ross, David M; Della Porta, Matteo G; Devos, Timothy; Rotunno, Giada; Komrokji, Rami S; Casetti, Ilaria C; Merli, Michele; Brociner, Marco; Caramazza, Domenica; Auteri, Giuseppe; Barbui, Tiziano; Cattaneo, Daniele; Bertù, Lorenza; Arcaini, Luca; Vannucchi, Alessandro M; Passamonti, Francesco
PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia 1-gen-2005 Passamonti, ; FRANCESCO; Pietra D; RUMI, ; Elisa;, Arcaini; LUCA; DELLA PORTA, ; LUCA; Pascutto C; LAZZARINO, ; Mario;, Cazzola; Mario, ; DELLA PORTA, MATTEO GIOVANNI
RECOMBINANT GAMMA-INTERFERON INDUCES INVITRO MONOCYTIC DIFFERENTIATION OF BLAST CELLS FROM PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA AND MYELODYSPLASTIC SYNDROMES 1-gen-1988 CARLO-STELLA, C.; Cazzola, M; Ganser, A; Bergamaschi, G; Meloni, F; Pedrazzoli, P; Bernasconi, P; Invernizzi, R; Hoelzer, D; Ascari, E
Reverse transcription polymerase chain reaction is a reliable assay for detecting leukemic colonies generated by chronic myelogenous leukemia cells 1-gen-1998 Savoldo, B; Sammarelli, G; Dotti, G; Garau, D; Regazzi, E; Cilloni, D; Tabilio, A; Rizzoli, V; Carlo-Stella, C.
Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS. 1-gen-2014 Porwit, A; van de Loosdrecht, Aa; Bettelheim, P; Brodersen, Le; Burbury, K; Cremers, E; Ireland, R; Johansson, U; Matarraz, S; Ogata, K; Orfao, A; Preijers, F; Psarra, K; Subirá, D; Valent, P; van der Velden, Vh; Wells, D; Westers, Tm; Kern, W; Béné, Mc; DELLA PORTA, MATTEO GIOVANNI
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. 1-gen-2012 DELLA PORTA, MATTEO GIOVANNI
The CIBMTR score predicts of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). 1-gen-2013 Todisco, E; Ciceri, F; Oldani, E; Boschini, C; Mice, C; Vanlint, M C; Donnini, I; Patriarca, F; Alessandrino, P E; Bonifazi, F; Arcese, W; Barberi, W; Marenco, P; Terruzzi, E; Cortellazzo, S; Santarone, S; Proia, A; Corradini, P; Tagliaferri, E; Falcioni, S; Irrera, G; Dallanegra, L; Castagna, L; Santoro, A; Camboni, A; Sacchi, N; Bosi, A; Bacigalupo, A; Rambaldi, A
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS 1-gen-2021 Kuendgen, A; Nomdedeu, M; Tuechler, H; Garcia-Manero, G; Komrokji, R S; Sekeres, M A; Della Porta, M G; Cazzola, M; Dezern, A E; Roboz, G J; Steensma, D P; Van de Loosdrecht, A A; Schlenk, R F; Grau, J; Calvo, X; Blum, S; Pereira, A; Valent, P; Costa, D; Giagounidis, A; Xicoy, B; Döhner, H; Platzbecker, U; Pedro, C; Lübbert, M; Oiartzabal, I; Díez-Campelo, M; Cedena, M T; Machherndl-Spandl, S; López-Pavía, M; Baldus, C D; Martinez-de-Sola, M; Stauder, R; Merchan, B; List, A; Ganster, C; Schroeder, T; Voso, M T; Pfeilstöcker, M; Sill, H; Hildebrandt, B; Esteve, J; Nomdedeu, B; Cobo, F; Haas, R; Sole, F; Germing, U; Greenberg, P L; Haase, D; Sanz, G
TUMOR-NECROSIS-FACTOR-ALPHA DOWN-REGULATES C-MYC MESSENGER-RNA EXPRESSION AND INDUCES INVITRO MONOCYTIC DIFFERENTIATION IN FRESH BLAST CELLS FROM PATIENTS WITH ACUTE MYELOBLASTIC-LEUKEMIA 1-gen-1990 Bergamaschi, G; CARLO-STELLA, C.; Cazzola, M; Defazio, P; Pedrazzoli, P; Peverali, Fa; Dellavalle, G
TUMOR-NECROSIS-FACTOR-ALPHA MODULATES THE MESSENGER-RNA EXPRESSION OF HEMATOPOIETIC GROWTH-FACTOR GENES IN FRESH BLAST CELLS FROM PATIENTS WITH ACUTE MYELOBLASTIC-LEUKEMIA 1-gen-1991 Bergamaschi, G; Cazzola, M; Rosti, V; CARLO STELLA, C.; Santini, V; Ponchio, L; Peverali, Fa; Dellavalle, G; Ferrini, Pr; Ascari, E
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM) 1-gen-2015 DELLA PORTA, MATTEO GIOVANNI; Tuechler, H; Malcovati, Luca; Schanz, J; Sanz, G; Garcia Manero, G; Solé, F; Bennett, Jm; Bowen, D; Fenaux, P; Dreyfus, F; Kantarjian, H; Kuendgen, A; Levis, A; Cermak, J; Fonatsch, C; Le Beau, Mm; Slovak, Ml; Krieger, O; Luebbert, M; Maciejewski, J; Magalhaes, Sm; Miyazaki, Y; Pfeilstöcker, M; Sekeres, Ma; Sperr, Wr; Stauder, R; Tauro, S; Valent, P; Vallespi, T; van de Loosdrecht, Aa; Germing, U; Haase, D; Greenberg, Pl; Cazzola, Mario
Mostrati risultati da 21 a 39 di 39
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile